chalcone has been researched along with B16 Melanoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashida, H; Bode, AM; Chang, X; Chen, H; Dong, Z; Fredimoses, M; Gao, G; Lee, MH; Lippman, SM; Ma, W; Oi, N; Rathore, MG; Reddy, K; Wang, K; Wang, Q; Wang, T; Yao, K; Zhang, T; Zykova, TA | 1 |
Bargsten, K; Benkheil, M; Bueno, O; Camarasa, MJ; Canela, MD; Díaz, JF; Jimeno, ML; Liekens, S; Noppen, S; Pérez-Pérez, MJ; Priego, EM; Prota, AE; Ribatti, D; Sáez-Calvo, G; Steinmetz, MO; Velázquez, S | 1 |
Hou, A; Hu, X; Wang, H; Zhang, X | 1 |
Takahashi, M; Takara, K; Toyozato, T; Wada, K | 1 |
Iwashita, K; Kobori, M; Tsushida, T; Yamaki, K | 1 |
5 other study(ies) available for chalcone and B16 Melanoma
Article | Year |
---|---|
The Ashitaba (
Topics: Angelica; Animals; Carcinogenesis; Cell Line, Tumor; Chalcone; Drug Screening Assays, Antitumor; Humans; Melanoma, Experimental; Mice; Mice, Knockout; Mutation; Phosphatidylinositol 3-Kinases; Plant Extracts; Proto-Oncogene Proteins B-raf; PTEN Phosphohydrolase; Signal Transduction; Skin Neoplasms; Treatment Outcome | 2018 |
Antivascular and antitumor properties of the tubulin-binding chalcone TUB091.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzodioxoles; Binding Sites; Breast Neoplasms; Cell Movement; Cell Proliferation; Cells, Cultured; Chalcone; Chalcones; Crystallography, X-Ray; Dipeptides; Endothelium, Vascular; Female; Humans; Melanoma, Experimental; Mice; Mice, SCID; Neovascularization, Pathologic; Prodrugs; Protein Binding; Protein Conformation; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays | 2017 |
Inhibitory effect of 2,4,2',4'-tetrahydroxy-3-(3-methyl-2-butenyl)-chalcone on tyrosinase activity and melanin biosynthesis.
Topics: alpha-MSH; Animals; Antioxidants; Cell Line, Tumor; Cell Survival; Chalcone; Dopamine Agents; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Inhibitory Concentration 50; Levodopa; Melanins; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Plant Extracts; Pyrones; RNA, Messenger | 2009 |
A novel bioactive chalcone of Morus australis inhibits tyrosinase activity and melanin biosynthesis in B16 melanoma cells.
Topics: Agaricales; Animals; Cell Survival; Chalcone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Melanins; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Morus; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells.
Topics: Animals; Apigenin; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Cell Division; Chalcone; Chalcones; Flavanones; Flavonoids; Genistein; Isoflavones; Luteolin; Melanoma, Experimental; Mice; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Quercetin; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |